NCT03032913View on ClinicalTrials.gov

Diagnostic Accuracy of Circulating Tumor Cells (CTCs) and Onco-exosome Quantification in the Diagnosis of Pancreatic Cancer - PANC-CTC

CompletedOBSERVATIONAL
Enrollment

52

Participants

Timeline

Start Date

February 15, 2017

Primary Completion Date

November 13, 2017

Study Completion Date

November 13, 2017

Conditions
Pancreatic Ductal Adenocarcinoma (PDAC)
Interventions
PROCEDURE

Blood samples

Blood samples for both group

PROCEDURE

Portal vein blood sample

Portal vein blood sample during surgery procedure for the Pancreatic Ductal Adenocarcinoma group

Trial Locations (1)

Unknown

Chu de Bordeaux, Bordeaux

All Listed Sponsors
lead

University Hospital, Bordeaux

OTHER

NCT03032913 - Diagnostic Accuracy of Circulating Tumor Cells (CTCs) and Onco-exosome Quantification in the Diagnosis of Pancreatic Cancer - PANC-CTC | Biotech Hunter | Biotech Hunter